Fertility and Pregnancy
Women with a mutation in the BRCA1 gene likely have fewer eggs in their ovaries than the average woman, which may shorten their window of opportunity to have children.
A study found that young men diagnosed with cancer were 4 to 5 times more likely to take steps to preserve fertility than young women diagnosed with cancer.
Concerns about fertility caused about 30% of younger women diagnosed with hormone-receptor-positive, early-stage breast cancer to skip or stop taking tamoxifen.
A meta-analysis suggests that women diagnosed with breast cancer who are treated with a luteinizing hormone-releasing hormone agonist in addition to chemotherapy may be more likely to become pregnant after chemotherapy ends.
Women diagnosed with early-stage breast cancer who were treated with Trelstar in addition to chemotherapy might find it easier to get pregnant after chemotherapy ends, but the results weren't definitive.
Another study suggests that infertility treatments don't appear to increase breast cancer risk.
Research shows that premenopausal women diagnosed with hormone-receptor-negative, early-stage breast cancer who were treated with Zoladex and chemotherapy were much less likely to be infertile.
A study found that women with a BRCA1 mutation had levels of a hormone that indicates how many eggs are left in the ovaries that were 25% lower than women who didn't have the mutation.
Research suggests that young women who get fertility counseling before cancer treatment have fewer regrets and better overall quality of life after treatment compared to women who don't get fertility counseling.
Most doctors advise women to wait two years after breast cancer treatment before becoming pregnant. New research suggests that women might not have to wait that long.
Five-year results found women diagnosed with early-stage, hormone-receptor-negative breast cancer who were treated with Zoladex in addition to chemotherapy before surgery were much less likely to be infertile after chemotherapy ended.
Women being treated for infertility do not have a higher risk of breast cancer.
Women with a history of infertility had denser breasts than women who didn't have fertility problems, and infertile women who had controlled ovarian stimulation had denser breasts than women who didn't have the treatment.
A study suggests that women who get pregnant after being diagnosed with breast cancer have the same recurrence risk as women who don't get pregnant after being diagnosed.
Infertility problems may be linked to lower breast cancer risk.
A large Dutch study strongly suggests that in vitro fertilization (IVF), a type of fertility treatment, doesn't appear to increase breast cancer risk, even years after the fertility treatment.
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
Most women can carry a baby to full term if diagnosed when pregnant; some treatments can be given during pregnancy while others should wait until after delivery.
A new analysis suggests that pregnancy doesn't negatively affect the future survival of women who've been diagnosed with breast cancer.
A study has found that the likelihood that a woman who's been diagnosed with cancer will get fertility counseling before cancer treatment starts depends on her race, educational background, and economic situation.
Infertility seems to double the risk of breast cancer in men.
Freezing embryos created from eggs extracted before treatment allowed women diagnosed with early-stage breast cancer to become pregnant at rates similar to women not diagnosed with breast cancer who underwent in vitro fertilization.
A study suggests that women younger than 50 who use fertility drugs to successfully conceive a child may see their risk of breast cancer go up. But this higher risk is about the same as the average woman's risk.
A meta-analysis suggests that premenopausal women diagnosed with early-stage breast cancer who are treated with gonadotropin-releasing hormone analog during chemotherapy are more likely to have their periods return after treatment ends and may be more likely to have children after breast cancer treatment.